Skip to main content

Rhenman & Partners Asset Management AB

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1599882 Stockholm, V7

Position in AXSM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,432,748
+$4,649,272 QoQ
Shares Held
63,050
-1.2% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#100
of 494 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. AXSM ranks #7 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 AXSM
Axsome Therapeutics, Inc.
This page
63,050 $15,432,748

All Filings in AXSM

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,432,748 63,050
2026-03-31 $10,783,476 63,800
2025-12-31 $20,967,072 114,800
2025-09-30 $20,986,560 172,800
2025-06-30 $9,478,612 90,800
2025-03-31 $12,782,648 109,600
2024-12-31 $10,373,186 122,600
2024-09-30 $11,018,062 122,600
2024-06-30 $10,271,800 127,600
2024-03-31 $11,459,280 143,600
2023-12-31 $6,295,569 79,100
2023-09-30 $2,802,589 40,100
2023-06-30 $2,881,586 40,100
2023-03-31 $925,200 15,000